Novavax, Inc. (NVAX)

Novavax Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	578.93	1,347	1,527	647.28	82.18
Short-Term Investments	0	0	0	157.65	0
Cash & Cash Equivalents	578.93	1,347	1,527	804.93	82.18
Cash Growth	-57.03%	-11.75%	89.66%	879.47%	-20.93%
Receivables	297.24	82.38	454.99	262.01	7.5
Inventory	41.7	36.68	8.87	0	0
Other Current Assets	226.02	237.15	164.65	181.26	7.57
Total Current Assets	1,144	1,703	2,155	1,248	97.25
Property, Plant & Equipment	490.99	400.49	265.86	179.95	11.45
Goodwill and Intangibles	127.45	126.33	131.48	141.1	56.74
Other Long-Term Assets	35.16	28.47	24.29	13.22	7.53
Total Long-Term Assets	653.6	555.29	421.63	334.28	75.71
Total Assets	1,797	2,259	2,577	1,582	172.96
Accounts Payable	132.61	216.52	127.05	54.33	2.91
Deferred Revenue	863.52	549.55	1,595	273.23	1.68
Current Debt	5.14	352.08	130.53	105.86	0
Other Current Liabilities	633.87	1,342	537.26	146.25	21.21
Total Current Liabilities	1,635	2,460	2,390	579.67	25.8
Long-Term Debt	223.94	197.7	323.46	362.12	320.61
Other Long-Term Liabilities	655.34	235.11	214.65	13.48	12.57
Total Long-Term Liabilities	879.28	432.81	538.11	375.6	333.18
Total Liabilities	2,514	2,893	2,928	955.27	358.97
Total Debt	229.08	549.78	453.99	467.98	320.61
Debt Growth	-58.33%	21.10%	-2.99%	45.97%	0.45%
Retained Earnings	-4,820.95	-4,275.89	-3,617.95	-1,874.2	-1,431.8
Comprehensive Income	2.72	-6.38	-1.35	7.02	-12.51
Shareholders' Equity	-716.93	-634.08	-351.67	627.21	-186.02
Net Cash / Debt	349.85	797.41	1,073	336.95	-238.43
Net Cash / Debt Growth	-56.13%	-25.66%	218.33%	-	-
Net Cash Per Share	3.47	10.20	14.42	5.85	-9.89
Working Capital	-491.25	-756.55	-235.2	668.53	71.45
Book Value Per Share	-7.12	-8.11	-4.73	10.90	-7.72

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).